Geode Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-745,761
| Closed | -$84K | – | 4182 |
|
|
2018
Q4 | $84K | Sell |
745,761
-1,671,330
| -69% | -$1.1M | ﹤0.01% | 3896 |
|
|
2018
Q3 | $4.11M | Buy |
2,417,091
+95,100
| +4% | +$170K | ﹤0.01% | 2475 |
|
|
2018
Q2 | $4.04M | Buy |
2,321,991
+286,942
| +14% | +$496K | ﹤0.01% | 2453 |
|
|
2018
Q1 | $3.72M | Buy |
2,035,049
+46,114
| +2% | +$97.4K | ﹤0.01% | 2423 |
|
|
2017
Q4 | $4.43M | Sell |
1,988,935
-49,366
| -2% | -$123K | ﹤0.01% | 2275 |
|
|
2017
Q3 | $5.91M | Buy |
2,038,301
+126,442
| +7% | +$431K | ﹤0.01% | 2096 |
|
|
2017
Q2 | $8.51M | Buy |
1,911,859
+241,671
| +14% | +$997K | ﹤0.01% | 1770 |
|
|
2017
Q1 | $7.78M | Buy |
1,670,188
+189,235
| +13% | +$1.1M | ﹤0.01% | 1791 |
|
|
2016
Q4 | $9.02M | Buy |
1,480,953
+126,915
| +9% | +$663K | ﹤0.01% | 1646 |
|
|
2016
Q3 | $7.46M | Buy |
1,354,038
+76,358
| +6% | +$357K | ﹤0.01% | 1686 |
|
|
2016
Q2 | $4.86M | Buy |
1,277,680
+557,946
| +78% | +$1.89M | ﹤0.01% | 1934 |
|
|
2016
Q1 | $1.99M | Buy |
719,734
+55,327
| +8% | +$200K | ﹤0.01% | 2468 |
|
|
2015
Q4 | $3.77M | Buy |
664,407
+11,247
| +2% | +$68.6K | ﹤0.01% | 2075 |
|
|
2015
Q3 | $3.46M | Buy |
653,160
+68,735
| +12% | +$532K | ﹤0.01% | 2082 |
|
|
2015
Q2 | $4.85M | Buy |
584,425
+12,142
| +2% | +$58.9K | ﹤0.01% | 1912 |
|
|
2015
Q1 | $2.64M | Buy |
572,283
+36,887
| +7% | +$120K | ﹤0.01% | 2267 |
|
|
2014
Q4 | $1.63M | Buy |
535,396
+41,599
| +8% | +$123K | ﹤0.01% | 2551 |
|
|
2014
Q3 | $1.38M | Buy |
493,797
+5,676
| +1% | +$20.6K | ﹤0.01% | 2588 |
|
|
2014
Q2 | $1.99M | Buy |
488,121
+47,105
| +11% | +$200K | ﹤0.01% | 2369 |
|
|
2014
Q1 | $2.34M | Buy |
441,016
+6,362
| +1% | +$35.7K | ﹤0.01% | 2244 |
|
|
2013
Q4 | $2.41M | Buy |
434,654
+26,601
| +7% | +$115K | ﹤0.01% | 2180 |
|
|
2013
Q3 | $1.84M | Buy |
408,053
+39,828
| +11% | +$179K | ﹤0.01% | 2229 |
|
|
2013
Q2 | $1.57M | Buy |
+368,225
| New | +$1.85M | ﹤0.01% | 2184 |
|
Other funds holding SGYP
Geode Capital Management's SGYP Position: Q1 2019 in Review
Geode Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 745,761 shares — an estimated $84K sold.
Geode Capital Management first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $9.02M in Q4 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Geode Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Geode Capital Management sold 745,761 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $84K.
- Geode Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- Geode Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $9.02M in Q4 2016.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Geode Capital Management's 13F filing for Q1 2019, filed 14 May 2019.